LG Life Sciences, Ltd. is engaged in manufacturing, supply and distribution pharmaceutical products, animal health products and specialty chemicals. The company operates in three business segments: Pharmaceuticals is engaged in the development and manufacturing of genetically-engineered interferon-gamma, interferon-alpha, hepatitis B vaccines, human growth hormones, leukocyte stimulants, malaria diagnostics and quinolone antibiotic; Animal health is engaged in the development and manufacturing of recombinant bovine somatotropin (bST, product name BOOSTIN®); and Specialty Chemicals is engaged in manufacturing active ingredients (actives) for agrochemicals and pharmaceutical intermediates such as Aminothiazole derivatives, Quinolone Antibiotics intermediate and Penicillin Antibiotics intermediate. LG Life Sciences, Ltd. is based in Seoul, South Korea with operations in markets including Thailand, India, Poland, China and Jordan. The company was incorporated in 2002.
Headquarters
Saemunan-ro Jongno-gu Seoul
Seoul; Seoul;
Postal Code: 150721
Contact Details: Purchase the LG Life Sciences, Ltd. report to view the information.
Website: http://www.lgls.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service